Phenominer Database Results (11 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Method Notes Record ID Study ID
COP/CrCrl mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 7 0.1 null 0.15 0.4 necropsy 0 11370 75
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 144 and 195 days) Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 mammary gland integrity trait female 203 days-264 days 34 3.9 null 0.6 3.5 manual palpation method 0 0 11752 144
BN/SsNHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 196 and 199 days) Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 mammary gland integrity trait female 259 days 13 0.0 null manual palpation method crystalline implant 0 11381 81
ACI.COP-(D6Rat80-D6Rat146)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 17 2.4 null 0.41 1.7 necropsy 0 11360 75
ACI.COP-(D10Mgh8-D10Rat4)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 12 4.8 null 1.04 3.6 necropsy 0 11366 75
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 mammary gland integrity trait female 143 days-259 days 22 8.8 null 1.4 6.57 manual palpation method 0.0 crystalline implant 0 11382 81
COP/OlaHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 212 and 330 days) Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 mammary gland integrity trait female 271 days-397 days 20 0.4 null 0.13 0.6 manual palpation method 0 0 11753 144
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 21 7.0 null 1.16 5.3 necropsy 0 11368 75
ACI.COP-(D3Rat130-D3Rat114)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 17 4.5 null 0.73 3.0 necropsy 0 11364 75
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 99 and 197 days) Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 mammary gland integrity trait female 160 days-260 days 20 5.6 null necropsy 0.0 0 tumor size reach 1-1.5 cm 11377 76
ACI.COP-(D3Mgh16-D3Rat119)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 8 4.3 null 1.13 3.2 necropsy 0 11362 75